Pier Capital, LLC Codexis, Inc. Transaction History

Pier Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$6.06 - $12.86 $2.63 Million - $5.58 Million	-433,924 Reduced 99.86%	619 $4,000
Q2 2022 Aug 15, 2022	BUY	$8.35 - $21.89 $860 - $2,254	103 Added 0.02%	434,543 $4.55 Million
Q1 2022 May 10, 2022	BUY	$16.97 - $31.93 $4.79 Million - $9 Million	281,989 Added 184.97%	434,440 $8.96 Million
Q4 2021 Feb 10, 2022	SELL	$25.61 - $41.78 $7.83 Million - $12.8 Million	-305,860 Reduced 66.74%	152,451 $4.77 Million
Q3 2021 Nov 10, 2021	SELL	$19.65 - $27.99 $3.53 Million - $5.03 Million	-179,787 Reduced 28.18%	458,311 $10.7 Million
Q2 2021 Aug 12, 2021	BUY	$17.48 - $25.46 $4.72 Million - $6.88 Million	270,075 Added 73.39%	638,098 $14.5 Million
Q1 2021 May 13, 2021	BUY	$18.08 - $28.8 $6.65 Million - $10.6 Million	368,023 New	368,023 $8.42 Million

144

60.6M

68.5K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $274M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.